<DOC>
	<DOC>NCT01201044</DOC>
	<brief_summary>The purpose of this study is to investigate the efficacy of BAI Plus 3DCRT in local advanced NSCLC.</brief_summary>
	<brief_title>Study to Investigate Bronchial Arterrial Infusing (BAI) Plus Three-dimensional Conformal Radiotherapy (3DCRT) in Local Advanced Non-small Cell Lung Cancer (NSCLC)</brief_title>
	<detailed_description />
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Nedaplatin</mesh_term>
	<criteria>stage IIIA&amp;IIIB NSCLC male or female, Age ≥18Years, ≤70Years Life expectation of at least 12weeks. PS performance 02 Measurable disease according to the Response Evaluation Criteria in Solid Tumours ( RECIST) Patient with prior chemotherapy or radiology for IIIA or IIIB NSCLC</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>BAI</keyword>
	<keyword>3DCRT</keyword>
</DOC>